New Treatment Guidelines for Restless Legs Syndrome and Shifting Away From Dopamine Agonists

Описание к видео New Treatment Guidelines for Restless Legs Syndrome and Shifting Away From Dopamine Agonists

John Winkelman, MD, PhD, the chief of the Sleep Disorders Clinical Research Program at Massachusetts General Hospital, talked about the new clinical guidelines for treating restless legs syndrome which emphasize the risks of dopamine agonists and advocate for alternative therapies.

Read More: https://www.neurologylive.com/view/ne...

Комментарии

Информация по комментариям в разработке